Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (iPLESP), AP-HP, Hôpital Saint-Antoine, Paris, France.
Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, Paris, France.
Genet Med. 2019 Sep;21(9):2151-2155. doi: 10.1038/s41436-019-0449-6. Epub 2019 Feb 11.
The SERPINA1 Z allele is associated with cystic fibrosis (CF)-related liver disease (CFLD), a common manifestation in patients with CF. We estimated CFLD incidence based on the SERPINA1 genotype in 3328 CF patients with CFLD-phenotype information.
The associations of SERPINA1 Z (rs28929474) and S (rs17580) alleles with age at CFLD onset and the development of CFLD-related complications (severe liver disease with cirrhosis, portal hypertension, esophageal varices) were analyzed.
Overall, 3% of patients carried the SERPINA1 Z allele and 13% carried the S allele. The cumulative incidence of CFLD increased more rapidly in patients carrying the Z allele (hazard ratio [HR] = 1.6; 95% confidence interval [CI] = 1.1-2.4, P = 0.019), reaching 47% by age 25 compared with 30% in noncarriers. Increased risk was similar for patients with severe CFLD (HR = 1.5, 95% CI = 0.7-3.2, P = 0.31) but failed to reach significance due to a limited sample size of Z-allele carriers. No significant effect was found for the S allele.
CF patients carrying the SERPINA1 Z allele had an increased risk of developing CFLD and related complications compared with noncarriers. Routine SERPINA1 Z genotyping upon CF diagnosis is warranted for identifying patients worthy of closer liver disease monitoring.
SERPINA1 Z 等位基因与囊性纤维化(CF)相关肝病(CFLD)相关,这是 CF 患者的常见表现。我们根据 3328 例具有 CFLD 表型信息的 CF 患者的 SERPINA1 基因型,估计 CFLD 的发病率。
分析 SERPINA1 Z(rs28929474)和 S(rs17580)等位基因与 CFLD 发病年龄以及 CFLD 相关并发症(严重肝病伴肝硬化、门静脉高压、食管静脉曲张)的发展之间的关系。
总体而言,3%的患者携带 SERPINA1 Z 等位基因,13%的患者携带 S 等位基因。携带 Z 等位基因的患者 CFLD 的累积发病率增长更快(危险比 [HR] = 1.6;95%置信区间 [CI] = 1.1-2.4,P = 0.019),与非携带者相比,25 岁时达到 47%,而 30 岁时达到 30%。严重 CFLD 患者的风险增加相似(HR = 1.5,95%CI = 0.7-3.2,P = 0.31),但由于 Z 等位基因携带者的样本量有限,未达到显著性。未发现 S 等位基因的显著影响。
与非携带者相比,携带 SERPINA1 Z 等位基因的 CF 患者发生 CFLD 和相关并发症的风险增加。CF 诊断时应常规进行 SERPINA1 Z 基因分型,以确定值得密切监测肝脏疾病的患者。